Multiresistant bacterial infections in liver cirrhosis: Clinical impact and new empirical antibiotic treatment policies

Figure 1 Increasing prevalence of multiresistant bacterial infections in a single center in Spain. Prevalence of multiresistant bacteria has doubled in the last decade (original work of the author). ^aP < 0.05 vs other periods.

Figure 2 Prevalence of multiresistant bacterial infections according to the site of acquisition. Multiresistant bacteria are present predominantly in the nosocomial and healthcare associated (HCA) infections. P value in both graphics refers to χ² linear-by-linear association statistic (original work of the author).